These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31623557)

  • 1. A case report on lipofuscin deposition in a graft biopsy two years after kidney transplantation: an insignificant bystander or a pathogenic benefactor?
    Leung VWY; Pilon SJ; Fiset PO; Sandal S
    BMC Nephrol; 2019 Oct; 20(1):376. PubMed ID: 31623557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
    Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T; Yamamoto I; Nakada Y; Kamejima S; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of C4d positive kidney allografts lacking histological signs of acute rejection.
    Dickenmann M; Steiger J; Descoeudres B; Mihatsch M; Nickeleit V
    Clin Nephrol; 2006 Mar; 65(3):173-9. PubMed ID: 16550748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
    Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
    Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Lipofuscin Deposition on Renal Allograft Tubular Epithelium Be a Surrogate Marker for Kidney Allograft Aging?
    Kawaguchi Y; Oguchi H; Mikami T; Yamaguchi Y; Ohashi Y; Kawamura T; Muramatsu M; Itabashi Y; Shinoda K; Hyodo Y; Takahashi Y; Onishi H; Arai T; Hamasaki Y; Shibuya K; Shishido S; Sakai K
    Transplant Proc; 2019 Jun; 51(5):1343-1347. PubMed ID: 31076149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher immunoglobulin A nephropathy recurrence in related-donor kidney transplants: The Japan Academic Consortium of Kidney Transplantation study.
    Okumi M; Okada D; Unagami K; Kakuta Y; Iizuka J; Takagi T; Shirakawa H; Omoto K; Ishida H; Tanabe K;
    Int J Urol; 2019 Sep; 26(9):903-909. PubMed ID: 31328329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
    Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study.
    Domański L; Kłoda K; Kwiatkowska E; Borowiecka E; Safranow K; Drozd A; Ciechanowicz A; Ciechanowski K
    BMC Nephrol; 2015 Feb; 16():23. PubMed ID: 25884882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
    Fujimoto T; Nakada Y; Yamamoto I; Kobayashi A; Tanno Y; Yamada H; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
    Yoon HE; Kim SH; Kim JY; Oh EJ; Park SC; Choi BS; Choi YJ; Moon IS; Kim YS; Yang CW
    Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology.
    Shimizu T; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2002; 16 Suppl 8():62-7. PubMed ID: 12464135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years.
    Sund S; Reisaeter AV; Fauchald P; Bentdal O; Hall KS; Hovig T
    Nephrol Dial Transplant; 1999 Oct; 14(10):2445-54. PubMed ID: 10528671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
    Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
    Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation.
    Katsuma A; Yamamoto I; Komatsuzaki Y; Niikura T; Kawabe M; Okabayashi Y; Yamakawa T; Katsumata H; Nakada Y; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():31-4. PubMed ID: 26971538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of late antibody-mediated rejection (C4d-mediated rejection): a single-center experience.
    Tatar E; Uslu A; Simsek C; Vardar E
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():259-62. PubMed ID: 25894167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE-Mediated Immune Response and Antibody-Mediated Rejection.
    Rascio F; Pontrelli P; Netti GS; Manno E; Infante B; Simone S; Castellano G; Ranieri E; Seveso M; Cozzi E; Gesualdo L; Stallone G; Grandaliano G
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1474-1483. PubMed ID: 32907809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Pathologic Features and Graft Outcomes of Rejection on Kidney Transplant.
    Park WY; Paek JH; Jin K; Park SB; Choe M; Han S
    Transplant Proc; 2019 Oct; 51(8):2655-2659. PubMed ID: 31345597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.